The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy-Reference-Cited by-同舟云学术

The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy

Published:2013-11-15 Issue:3 Volume:29 Page:380-387
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Baudrexel Simon¹²,Seifried Carola¹,Penndorf Bianca¹,Klein Johannes C.¹,Middendorp Marcus³,Steinmetz Helmuth¹,Grünwald Frank³,Hilker Rüdiger¹

Affiliation:

1. Department of Neurology; University Hospital, Goethe University Frankfurt am Main; Frankfurt am Main Germany

2. Brain Imaging Center; Goethe University Frankfurt am Main; Frankfurt am Main Germany

3. Department of Nuclear Medicine; University Hospital; Goethe University Frankfurt am Main; Frankfurt am Main Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference38 articles.

1. Multiple system atrophy;Wenning;Lancet Neurol,2004

2. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations;Ozawa;Brain,2004

3. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology;Papp;Brain,1994

4. Multiple system atrophy: a review of 203 pathologically proven cases;Wenning;Mov Disord,1997

5. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study;Litvan;Arch Neurol,1997

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism;EJNMMI Research;2023-08-12

2. Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy;European Radiology;2023-05-01

3. Neuroimaging in multiple system atrophy;Neuroimaging in Parkinson�s Disease and Related Disorders;2023

4. Neuroimaging in progressive supranuclear palsy;Neuroimaging in Parkinson�s Disease and Related Disorders;2023

5. Research Applications of Positron Emission Tomography/Magnetic Resonance (PET/MR) Imaging in Parkinson’s Disease (PD);PET/MR: Functional and Molecular Imaging of Neurological Diseases and Neurosciences;2023